Wada test using secobarbital sodium (Ional) to determine language dominance

Area of Science:

• Neurology
• Neuroscience
• Pharmacology

Background:

• The intracarotid sodium amobarbital (Amytal) test, or Wada test, is standard for evaluating language and memory preoperatively.
• A global shortage of amobarbital necessitates exploring alternative agents for this critical diagnostic procedure.

Purpose of the Study:

• To assess the efficacy and safety of secobarbital sodium as a substitute for amobarbital in the Wada test for determining language dominance.
• To evaluate the clinical utility of secobarbital sodium in preoperative language lateralization.

Main Methods:

• The Wada test was performed using secobarbital sodium in 43 patients requiring preoperative language dominance assessment.
• Patients' vital signs, neurological status, and EEG were monitored during and after the procedure.
• Specific monitoring included continuous intra-arterial blood pressure and scalp electroencephalography in a subset of patients.

Main Results:

• Secobarbital sodium successfully determined language dominance in all 43 patients.
• Minimal changes in vital signs were observed, and neurological deficits resolved within 8 minutes.
• Electroencephalography showed ipsilateral theta waves post-injection, resolving within 6 minutes. One patient experienced a transient scintillating scotoma, and another had a brief epileptic episode; no other adverse events occurred.

Conclusions:

• Secobarbital sodium is a safe and reliable alternative to amobarbital for the Wada test in determining language dominance.
• The findings support the use of secobarbital sodium to overcome amobarbital shortages and maintain essential preoperative neurodiagnostic capabilities.